Status:
RECRUITING
The Effect of Exercise Training on Quality of Life and Disease Progression in Fibrosing Interstitial Lung Patients
Lead Sponsor:
Istanbul Medipol University Hospital
Conditions:
Fibrosis, Pulmonary
Pulmonary Rehabilitation
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
In this study, the progression of the disease and changes in quality of life will be examined over a 1-year follow-up period in groups of patients with Fibrosing Interstitial Lung Disease who either p...
Detailed Description
Patients diagnosed with fibrosing lung disease by a pulmonology specialist at Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital will be included in the study. Those meeting t...
Eligibility Criteria
Inclusion
- Aged between 18-75 years
- Diagnosed with fibrosing interstitial lung disease according to the clinical diagnostic criteria of the American Thoracic Society and European Respiratory Society (ATS-ERS)
- Presence of dyspnea on exertion
- Stable clinical condition at the time of inclusion without infection or exacerbation in the previous 4 weeks
- Proficiency in using a smartphone
Exclusion
- Severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases, or requiring high-flow oxygen therapy (\> 3-4 L/min)
- History of exertional syncope or any comorbidity that prevents exercise training (such as severe orthopedic or neurological deficits or unstable heart disease)
- Participation in a pulmonary rehabilitation program within the last 12 months
Key Trial Info
Start Date :
July 29 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT06527612
Start Date
July 29 2024
End Date
August 1 2026
Last Update
August 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Esra Pehli̇van
Istanbul, Üsküdar, Turkey (Türkiye), 34668